Evidence map›Paper›PMID 28469117›Full record

ArticleAnnals of African medicine

Neonatal sepsis in a Nigerian private tertiary hospital: Bacterial isolates, risk factors, and antibiotic susceptibility patterns.

Emmanuel Olushola Shobowale, Adaobi U Solarin, Charles John Elikwu, Kenneth Ikenna Onyedibe, Ibironke J Akinola, Abiodun A Faniran

Open access · greenAbstract read
In one paragraph

Article in Annals of African medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A Case of Sepsis Due to Carbapenem-ResistantInfection and drug resistance · 2021
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Emmanuel Olushola ShobowaleDepartment of Medical Microbiology and Parasitology, Ben Carson School of Medicine, Babcock University, Ilishan-Remo, Ogun State, Nigeria.
Adaobi U SolarinDepartment of Pediatrics, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Charles John ElikwuDepartment of Medical Microbiology and Parasitology, Ben Carson School of Medicine, Babcock University, Ilishan-Remo, Ogun State, Nigeria.
Kenneth Ikenna OnyedibeDepartment of Medical Microbiology and Parasitology, College of Medicine University of Jos, Jos, Nigeria.
Ibironke J AkinolaDepartment of Pediatrics, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Abiodun A FaniranDepartment of Pediatrics, Babcock University Teaching Hospital, Ilishan-Remo, Ogun State, Nigeria.
Babcock University · NGLagos State University Teaching Hospital · NGUniversity of Jos · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesNeonatal sepsis is an important cause of morbidity and mortality in the pediatric age group in spite of several attempts at mitigating its effects. This article determines the prevalence of neonatal sepsis and the pathogens responsible for sepsis as well as risk factors and outcome at the Babcock University Teaching Hospital.

methodsA retrospective analysis of laboratory records of consecutive babies delivered within and outside our hospital suspected of having sepsis over a 1-year period.

resultsThe isolation rate was 34% from 100 neonates with the predominant pathogens being coagulase-negative staphylococci (CONS), Staphylococcus aureus, and Klebsiella pneumoniae. The risk factors for sepsis were age <3 days (P = 0.03) and prematurity (P < 0.001). The mortality rate was 12% with risk factors for mortality being birth weight <2500 g (P = 0.005), prematurity (P = 0.036), premature rupture of membranes (P = 0.007), and delivery outside a tertiary hospital (P = 0.007). Meropenem, ciprofloxacin, and amikacin showed the highest rates of in vitro efficacy.

conclusionWe highlight the prevalent pathogens in our local facility to be a combination of CONS, S. aureus, and K. pneumoniae with susceptibility patterns showing meropenem, ciprofloxacin, and amikacin to be our most effective antimicrobials in vitro.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsCross-Sectional StudiesFemaleHospitals, PrivateHumansInfant, NewbornKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsNeonatal ScreeningNeonatal SepsisPrevalenceRetrospective StudiesRisk FactorsAnti-Bacterial Agents

Identifiers

PMID28469117
PMCPMC5452709
OpenAlexW2608589566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.